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Objective: Acardiac twin occurs in 1:35,000 pregnancies. Several techniques have been described to treat
this condition. Some techniques have been suggested as golden standard; however, new are still being
tried.
Case report: This is a case of a 32-year-old patient who had successful ablation of the acardiac twin with
Histoacryl. The diagnosis of the acardiac twin was made in the 11 weeks þ 3 weeks of pregnancy. Due to
the development of myocardial hypertrophy and pericardial transudate of the pumping fetus, we had
performed ablation of the acardiac twin with Histoacryl in the 21 weeks' þ5 weeks' gestation. The
procedure was uneventful, and the healthy fetus had no signs of distress. In the 33 weeks' þ5 weeks'
gestation, she had Cesarean section due to distress of the healthy fetus. The female baby was healthy,
weighing 2380 g, Apgar score 9/10. The mummiﬁed mass of acardiac fetus weighted 300 g. Nine months
later, the child is doing well.
Conclusion: Histoacryl is suitable for the ablation of an acardiac twin. Further studies are needed to prove
the efﬁcacy of this technique.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
An acardiac-twin pregnancy occurs very rarely, only in 1:35,000
deliveries and in one in 100 monozygotic twins [1]. The twins are
always monochorionic. The pathomechanism of the acardiac-twin
formation lies in the preexistence of arterio-arterial anastomosis,
either on the surface of the placenta or in the placental arterial
system, or more rarely as a direct connection of the fetal umbilical
cords [2]. Thus, the acardiac twin does not have its own placenta,
and the arterial pressure of one twin overpowers that of the other
twin. It is rare, but for the healthy fetus, a very serious complication.
The acardiac twin does not have its own heart pump, and its
function is overtaken by the heart of the healthy sibling with all the
circulation consequences on it. The blood ﬂow of the acardiac twin
is then reversed. The whole mechanism creates a so-called twin-
reversed-arterial-perfusion sequence. In most cases, the head and
upper body of the acardiac twin do not develop. The healthy fetus
develops arterial-steal phenomenon with the development of car-
diac insufﬁciency, polyhydramnion, and consequently heart failure.gy and Obstetrics, School of
, Bratislava, Slovakia.
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we have several therapeutic possibilities. The treatment of choice is
selected according to the week of the pregnancy and the level of
development of each of the mentioned pathomechanism. At hand,
we have the possibility of pregnancy termination, expectation
management, intrafetal ablation, or interventional anastomosis
sclerotization (alcohol ablation, thermal ablation, laser ablation,
bipolar coagulation). Several new techniques, like radiofrequency
ablation, are being investigated, but more studies are needed to
prove their safety and efﬁcacy [3]. Based on these reports, we have
tried to treat the condition of acardiac-twin pregnancy by, in other
medical ﬁelds, a well-tried method. We have used TissueSeal's
Histoacryl (B-Braun, Bratislava, Slovakia) in order to occlude the
circulation of the acardiac twin and interrupt the twin-reversed-
arterial-perfusion sequence. Histoacryl is used as a tissue seal for
wound closure or for vessel closure by interventional radiologists. It
consists of monomeric n-butyl-2-cyanoacrylate, which polymer-
izes quickly in connection with tissue ﬂuid.
Case Report
We have diagnosed an acardiac twin in the 12th week of
pregnancy in a 35-year-old patient, gravida 2, para 1, with biam-
nionic monochorial twin pregnancy. The patient, after being fullyy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1. Magnetic-resonance-imaging scan of the healthy and acardiac fetus after
ablation.
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Further ultrasound examinations revealed that the acardiac twin
did not develop head, skull, and upper extremities. The stomach
was absent and the trunk absently ended with multiseptal
hygroma. Until the 17th week, the healthy fetus did not show signs
of fetal distress. We have performed prenatal echocardiography of
the “pumping fetus” in the 20th week of the pregnancy. It has
developed myocardial hypertrophy and pericardial transudate.
Because of the presumed development of chronic fetal hypoxia
and consequently congenital heart failure in the 21 weeks þ 5
weeks of pregnancy, after fully informing the mother about the
status of the fetus, we have performed intrauterine intervention
by intra-arterial ablation of the acardiac twin. As the ablation
material, we have used 0.3 mL of TissueSeal's Histoacryl, diluted
by 6:1 ratio with a diluting liquid (Lipiodol Ultra Fluid, GUERBET,
France). Under ultrasound guidance, we have inserted a 22-gauge
needle into the acardiac-twin main feeding umbilical-cord vessel.
We have then applied the ablating material in 5% glucose during
30 seconds. Glucose was used, because in contact with saline or
other material, the tissue glue agglutinates. Consequently, after
the application of the material, the blood ﬂow of the acardiac twin
has stopped immediately. At the same time, the healthy twin didFigure 2. (A) Acardiac fetus with placenta after delivery. (B)not show signs of increased distress and had normal heart rate.
The whole procedure took 12 minutes. Further observations of the
pumping twin showed normal heart rate and Doppler ﬂowmetry.
The patient was released from the hospital after 2 days of follow-
up with planned outpatient visits. In the following weeks, the
heart function of the healthy fetus restored, including the peri-
cardial transudate. The fetus grew in physiological margins.
Meanwhile, the acardiac twin showed signs of mummiﬁcation and
slow shrinkage, with no inﬂuence on the healthy fetus. The
amniotic-ﬂuid volume of the acardiac twin reduced continuously
(Figure 1). In the 33rd week of pregnancy, 11 weeks after the
intervention, the fetus showed signs of distress, and pathological
levels of umbilical-blood-ﬂow indexes with signs of fetal blood-
ﬂow centralization. Therefore, after the corticoid lung prepara-
tion of the fetus, we have performed delivery by Cesarean section
in the 33 weeks þ 5 weeks of pregnancy. The female baby was
healthy, weighing 2380 g, with Apgar score 9/10, umbilical blood
pH 7.22, with base excess 4.6 mmol/L. The acardiac female fetus
resembled a mummiﬁed mass weighing 300 g (Figure 2A). The X-
ray examination of the acardiac fetus with placenta revealed foci
of Histoacryl in the umbilical cord of the acardiac twin (Figure 2B).
Nine months after the delivery, the surviving child is doing well
with no signs of related embolic phenomenon.Discussion
Several attempts have been made to occlude the umbilical ar-
tery of the acardiac twin, including fetal ablation or interventional
anastomosis closure (e.g., laser ablation, alcohol ablation, ter-
moablation) [4]. This case has shown a different possibility of
invasive intrauterine treatment approach to acardiac twins with a
tissue-sealing material. We have tried this technique because of its
presumed safety, simplicity, and experience in treating adult-
patient conditions by interventional radiologists. Since our insti-
tution is a tertiary medical university center, under our laws, we
did not need an agreement from the regional ethics committee.
However, the patient had to sign a detailed informed consent, and
was fully acknowledged before the intervention. Even though the
golden standard in these cases is considered laser ablation, it
cannot be used in every patient [5]. In each case, an individual
approach and management are necessary. In order to prevent
preterm premature rupture of membranes after fetal ablation,
mini-invasive techniques have to be selected. For laser techniques,
a relatively big insertion into the intra-amnionic space is needed,
which is associated with a higher risk of preterm prematureX-ray picture with hyperechogenic places of Histoacryl.
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gauge needle and the application of TissueSeal's Histoacryl as the
least invasive type of procedure. Furthermore, the acardiac twin
can be developed into several different types, and according to
this, the appropriate technique and approach have to be selected
[3,6]. We think that, in case of intervention, the decision has to be
made as early as possible and the intervention performed in the
earlier weeks of the pregnancy. This way, we can avoid some
speciﬁc complications associated with acardiac-twin feticide [7,8].
Some authors describe umbilical-cord transection to be effective
in these cases [9]. However, we think that these approaches mean
too big interventional and represent a high risk for the course of
the pregnancy. Ville [5] describes a high percentage of failure
when using this laser ablation, even though it is considered to be
the standard care of therapy. In order to minimize the risks, we
have used a “tissue-sealing” material, Histoacryl. The material has
appropriate qualities for vascular closure and even for amnion-
defect closure [10]. The extremely fast complete closure of the
acardiac-fetus vascular system even prevented blood-steal phe-
nomenon from the healthy fetus. There are no data about using
Histoacryl in the treatment during pregnancy. However, it is a
widely used material by interventional radiologists for ablation of
tumors and in surgery as wound closure [11]. Its price is V75, and
it is fully covered by health insurance.
According to our experience, it seems that Histoacryl is also a
suitable material for the ablation of an acardiac twin and for the
safety of the mother. However, further experience is needed in
order to prove its efﬁcacy.Conﬂicts of interest
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